Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-06-20 Sale | 2025-06-23 7:42 pm | Axsome Therapeutics Inc. | AXSM | Murdock Hunter R. General Counsel | 13,514 | $101.42 | $1,370,647 | 38,752 (Direct) | View |
| 2025-06-16 Sale | 2025-06-18 9:16 pm | Axsome Therapeutics Inc. | AXSM | Murdock Hunter R. General Counsel | 22,500 | $101.19 | $2,276,850 | 112,149 (Direct) | View |
| 2025-06-09 Sale | 2025-06-10 7:00 pm | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 25,000 | $110.44 | $2,761,000 | 5,783 (Direct) | View |
| 2025-05-27 Sale | 2025-05-29 7:00 pm | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 7,500 | $104.45 | $783,375 | 450,493 (Indirect Direct) | View |
| 2025-05-27 Sale | 2025-05-28 9:52 pm | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 40,673 | $104.07 | $4,232,636 | 5,783 (Direct) | View |
| 2025-05-20 Sale | 2025-05-20 9:46 pm | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 3,000 | $107.49 | $322,473 | 457,993 (Indirect Direct) | View |
| 2025-02-13 Sale | 2025-02-14 9:20 pm | Axsome Therapeutics Inc. | AXSM | Pizzie Nick Chief Financial Officer | 15,000 | $130.1 | $1,951,530 | 42,675 (Indirect Direct) | View |
| 2024-09-11 Sale | 2024-09-11 7:00 pm | Axsome Therapeutics Inc. | AXSM | Saad Mark E Director | 11,016 | $91.31 | $1,005,871 | 10,302 (Indirect Direct) | View |
| 2024-08-09 Sale | 2024-08-09 7:27 pm | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 47,739 | $84.26 | $4,022,488 | 5,783 (Direct) | View |
| 2024-05-29 Sale | 2024-05-29 8:12 pm | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 7,910 | $74.31 | $587,813 | 5,783 (Direct) | View |
| 2024-05-28 Sale | 2024-05-29 8:11 pm | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 10,497 | $75.17 | $789,107 | 14,600 (Direct) | View |
| 2024-04-01 Sale | 2024-04-01 6:46 pm | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 24,662 | $77.24 | $1,904,942 | 0 (Direct) | View |
| 2024-03-14 Sale | 2024-03-15 8:05 pm | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 32,323 | $69.84 | $2,257,449 | 167,668 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-20 Exercise | 2025-06-23 7:42 pm | 2023-03-04 2032-03-04 | Axsome Therapeutics Inc. | AXSM | Murdock Hunter R. General Counsel | 13,514 | $0 | 38,752 (Direct) | View |
| 2025-06-20 Exercise | 2025-06-23 7:42 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Murdock Hunter R. General Counsel | 13,514 | $29.91 | 38,752 (Direct) | View |
| 2025-06-16 Exercise | 2025-06-18 9:16 pm | 2023-03-04 2032-03-04 | Axsome Therapeutics Inc. | AXSM | Murdock Hunter R. General Counsel | 22,500 | $0 | 112,149 (Direct) | View |
| 2025-06-16 Exercise | 2025-06-18 9:16 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Murdock Hunter R. General Counsel | 22,500 | $29.91 | 112,149 (Direct) | View |
| 2025-06-06 Option Award | 2025-06-10 7:00 pm | N/A 2035-06-06 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 4,595 | $0 | 4,595 (Direct) | View |
| 2025-06-06 Option Award | 2025-06-10 7:00 pm | N/A 2035-06-06 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 4,595 | $0 | 4,595 (Direct) | View |
| 2025-06-06 Option Award | 2025-06-10 7:00 pm | N/A 2035-06-06 | Axsome Therapeutics Inc. | AXSM | Saad Mark E Director | 4,595 | $0 | 4,595 (Direct) | View |
| 2025-06-09 Exercise | 2025-06-10 7:00 pm | 2017-05-27 2026-05-27 | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 25,000 | $0 | 5,783 (Direct) | View |
| 2025-06-09 Exercise | 2025-06-10 7:00 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 25,000 | $8.02 | 5,783 (Direct) | View |
| 2025-06-06 Option Award | 2025-06-10 7:00 pm | N/A 2035-06-06 | Axsome Therapeutics Inc. | AXSM | Mahony Susan Director | 4,595 | $0 | 4,595 (Direct) | View |
| 2025-05-27 Exercise | 2025-05-28 9:52 pm | 2016-09-15 2025-09-15 | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 40,673 | $0 | 5,783 (Direct) | View |
| 2025-05-27 Exercise | 2025-05-28 9:52 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 40,673 | $6.47 | 5,783 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-25 8:02 pm | 2025-02-21 2035-02-20 | Axsome Therapeutics Inc. | AXSM | Mahony Susan Director | 1,312 | $0 | 1,312 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-25 8:00 pm | 2025-02-21 2035-02-20 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 1,408 | $0 | 1,408 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-25 7:59 pm | 2025-02-21 2035-02-20 | Axsome Therapeutics Inc. | AXSM | Saad Mark E Director | 1,494 | $0 | 1,494 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-25 7:57 pm | N/A 2035-02-20 | Axsome Therapeutics Inc. | AXSM | Maizel Ari Chief Commercial Officer | 23,296 | $0 | 23,296 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-25 7:56 pm | N/A 2035-02-20 | Axsome Therapeutics Inc. | AXSM | Murdock Hunter R. General Counsel | 23,296 | $0 | 23,296 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-25 7:54 pm | N/A 2035-02-20 | Axsome Therapeutics Inc. | AXSM | Pizzie Nick Chief Financial Officer | 28,362 | $0 | 28,362 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-25 7:53 pm | N/A 2035-02-20 | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 32,413 | $0 | 32,413 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-25 7:51 pm | N/A 2035-02-20 | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 86,105 | $0 | 86,105 (Direct) | View |
| 2025-02-13 Exercise | 2025-02-14 9:20 pm | 2019-05-16 2028-05-16 | Axsome Therapeutics Inc. | AXSM | Pizzie Nick Chief Financial Officer | 15,000 | $3.5 | 42,675 (Direct) | View |
| 2025-01-03 Exercise | 2025-01-06 4:06 pm | 2016-11-19 2025-11-19 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 9,127 | $0 | 460,993 (Direct) | View |
| 2025-01-03 Exercise | 2025-01-06 4:06 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 9,127 | $9 | 460,993 (Direct) | View |
| 2024-11-19 Exercise | 2024-11-20 4:30 pm | 2015-06-29 2025-06-29 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 33,410 | $0 | 451,866 (Direct) | View |
| 2024-11-19 Exercise | 2024-11-20 4:30 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 33,410 | $5.94 | 451,866 (Direct) | View |
Ownership | 2024-10-24 6:23 pm | N/A 2033-09-25 | Axsome Therapeutics Inc. | AXSM | Maizel Ari Chief Commercial Officer | 0 | $0 | 91,561 (Direct) | View |
| 2024-09-11 Exercise | 2024-09-11 7:00 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Saad Mark E Director | 11,016 | $3.67 | 10,302 (Direct) | View |
| 2024-09-11 Exercise | 2024-09-11 7:00 pm | 2015-09-16 2024-09-16 | Axsome Therapeutics Inc. | AXSM | Saad Mark E Director | 11,016 | $0 | 10,302 (Direct) | View |
| 2024-08-09 Exercise | 2024-08-09 7:27 pm | 2015-12-29 2024-12-29 | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 47,739 | $0 | 5,783 (Direct) | View |
| 2024-08-09 Exercise | 2024-08-09 7:27 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 47,739 | $4.04 | 5,783 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-11 4:32 pm | 2025-06-07 2034-06-07 | Axsome Therapeutics Inc. | AXSM | Mahony Susan Director | 5,799 | $0 | 5,799 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-11 4:31 pm | 2025-06-07 2034-06-07 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 5,799 | $0 | 5,799 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-11 4:31 pm | 2025-06-07 2034-06-07 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 5,799 | $0 | 5,799 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-11 4:30 pm | 2025-06-07 2034-06-07 | Axsome Therapeutics Inc. | AXSM | Saad Mark E Director | 5,799 | $0 | 5,799 (Direct) | View |
| 2024-05-29 Exercise | 2024-05-29 8:12 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 13,693 | $1.3 | 5,783 (Direct) | View |
| 2024-05-29 Exercise | 2024-05-29 8:12 pm | 2015-08-15 2024-06-18 | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 13,693 | $0 | 5,783 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-01 6:46 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 24,662 | $1.3 | 0 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-01 6:46 pm | 2014-10-03 2024-04-03 | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 24,662 | $0 | 0 (Direct) | View |
| 2024-03-14 Exercise | 2024-03-15 8:05 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 16,976 | $25.53 | 167,668 (Direct) | View |
| 2024-03-14 Exercise | 2024-03-15 8:05 pm | 2020-06-07 2029-06-07 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 32,323 | $0 | 167,668 (Direct) | View |
| 2024-03-15 Exercise | 2024-03-15 8:05 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 2,347 | $29.91 | 167,668 (Direct) | View |
| 2024-03-14 Exercise | 2024-03-15 8:05 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 13,000 | $22.03 | 167,668 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 6:34 pm | 2024-02-27 2034-02-26 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 1,425 | $0 | 1,425 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 6:34 pm | 2024-02-27 2034-02-26 | Axsome Therapeutics Inc. | AXSM | Saad Mark E Director | 1,519 | $0 | 1,519 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 6:34 pm | N/A 2034-02-26 | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. CHIEF OPERATING OFFICER | 50,852 | $0 | 50,852 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 6:25 pm | N/A 2034-02-26 | Axsome Therapeutics Inc. | AXSM | Pizzie Nick CHIEF FINANCIAL OFFICER | 44,496 | $0 | 44,496 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 6:20 pm | N/A 2034-02-26 | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER 10% Owner | 135,078 | $0 | 135,078 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 6:18 pm | 2024-02-27 2034-02-26 | Axsome Therapeutics Inc. | AXSM | Mahony Susan Director | 191 | $0 | 191 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 5:39 pm | N/A 2034-02-26 | Axsome Therapeutics Inc. | AXSM | Murdock Hunter R. General Counsel | 36,549 | $0 | 36,549 (Direct) | View |
| 2023-10-10 Option Award | 2023-10-12 8:33 pm | 2024-10-10 2033-10-10 | Axsome Therapeutics Inc. | AXSM | Mahony Susan Director | 7,375 | $0 | 7,375 (Direct) | View |